DarioHealthDRIO +7.85%58 Market Cap is $53.06 Mil as of Jul. 03, 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.09 (Fairly Valued). The stock has 4 warning signs investors should review. Among 695 Healthcare Providers & Services companies, DarioHealth ranks worse than 61.44% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DarioHealth's share price for the quarter that ended in Mar. 2026 was $8.02. DarioHealth's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 7.30 Mil. Therefore, DarioHealth's market cap for the quarter that ended in Mar. 2026 was $58.54 Mil.
DarioHealth's quarterly market cap
declined
from Sep. 2025 ($117.42 Mil) to Dec. 2025 ($78.59 Mil) and
declined
from Dec. 2025 ($78.59 Mil) to Mar. 2026 ($58.54 Mil).
DarioHealth's annual market cap
declined
from Dec. 2023 ($46.78 Mil) to Dec. 2024 ($30.17 Mil) but then
increased
from Dec. 2024 ($30.17 Mil) to Dec. 2025 ($78.59 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DarioHealth's Enterprise Value for Today is $65.04 Mil.
DarioHealth (NAS:DRIO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DarioHealth Market Cap Related Terms
DarioHealth Market Cap Historical Data
* Premium members only.
The historical data trend for DarioHealth's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, DarioHealth's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Market Cap distribution charts can be found below:
* The bar in red indicates where DarioHealth's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DarioHealth's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth (DRIO) has a Market Cap of $53.06 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DarioHealth and its competitors. According to the industry distribution chart, DarioHealth ranks #427 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 61.4%.
Is DarioHealth's Market Cap too high?
DarioHealth's current Market Cap is $53.06 Mil. The Healthcare Providers & Services industry median Market Cap is 96.57. DarioHealth's value of $53.06 Mil is 45.1% below this industry median. Based on the distribution chart, DarioHealth ranks #427 out of 695 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Market Cap compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #427 out of 695 companies for Market Cap. This places DarioHealth in the lower half of its industry. The industry median Market Cap is 96.57. DarioHealth's value of $53.06 Mil is 45.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DarioHealth's current Market Cap of $53.06 Mil is 45.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current Market Cap is $53.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.09, compared to a current price of $7.26 — trading 2.3% above its estimated fair value. The current Market Cap is $53.06 Mil and 45.1% below the Healthcare Providers & Services industry median of 96.57. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DarioHealth (DRIO), the current Market Cap is $53.06 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued.
The current stock price of $7.26 is trading 2.3% above its estimated GF Value™ of $7.09.
GuruFocus considers DarioHealth to be Fairly Valued.
Key valuation signals for DRIO:
Market Cap: $53.06 Mil
GF Value™: $7.09 vs. price of $7.26 (2.3% above fair value)
Industry Position: 45.1% below the Healthcare Providers & Services median (#427 of 695)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score
Get the complete analysis for DRIO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
